Hypoxemia in COVID-19; Comment on: "The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients".
作者信息
Coen Matteo, Allali Gilles, Adler Dan, Serratrice Jacques
机构信息
Service of Internal Medicine, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland.
Unit of Development and Research in Medical Education (UDREM), Faculty of Medicine, University of Geneva, Geneva, Switzerland.
出版信息
J Med Virol. 2020 Oct;92(10):1705-1706. doi: 10.1002/jmv.26020. Epub 2020 Jul 27.
Abstract
摘要
相似文献
1
Hypoxemia in COVID-19; Comment on: "The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients".新型冠状病毒肺炎中的低氧血症；评论：“SARS-CoV-2的神经侵袭潜力可能在新型冠状病毒肺炎患者的呼吸衰竭中起作用”
J Med Virol. 2020 Oct;92(10):1705-1706. doi: 10.1002/jmv.26020. Epub 2020 Jul 27.
2
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.SARS-CoV2 的神经侵袭性可能在 COVID-19 患者的呼吸衰竭中起作用。
J Med Virol. 2020 Jun;92(6):552-555. doi: 10.1002/jmv.25728. Epub 2020 Mar 11.
3
Beyond silent hypoxemia: Does COVID-19 can blunt pain perception? Comment on "The neuroinvasive potential of SARS CoV2 may play a role in the respiratory failure of COVID 19 patients".超越静息性低氧血症：新型冠状病毒肺炎会钝化痛觉吗？评《严重急性呼吸综合征冠状病毒2的神经侵袭潜能可能在新型冠状病毒肺炎患者呼吸衰竭中起作用》
J Med Virol. 2021 Apr;93(4):1915-1916. doi: 10.1002/jmv.26753. Epub 2020 Dec 29.
4
Response to Commentary on "The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients".对“SARS-CoV-2 的神经侵袭潜力可能在 COVID-19 患者呼吸衰竭中起作用”一文的评论的回应。
J Med Virol. 2020 Jul;92(7):707-709. doi: 10.1002/jmv.25824. Epub 2020 Apr 10.
5
Comment on "The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients".评“SARS-CoV-2 的神经侵袭性可能在 COVID-19 患者呼吸衰竭中起作用”一文。
J Med Virol. 2020 Jul;92(7):703-704. doi: 10.1002/jmv.25960. Epub 2020 May 22.
6
Computing the Effects of SARS-CoV-2 on Respiration Regulatory Mechanisms in COVID-19.计算 SARS-CoV-2 对 COVID-19 中呼吸调节机制的影响。
ACS Chem Neurosci. 2020 Aug 19;11(16):2416-2421. doi: 10.1021/acschemneuro.0c00349. Epub 2020 Aug 11.
7
Neuroinvasive potential of a primary respiratory pathogen SARS- CoV2: Summarizing the evidences.原发性呼吸道病原体SARS-CoV-2的神经侵袭潜力：证据总结
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1053-1060. doi: 10.1016/j.dsx.2020.06.062. Epub 2020 Jul 2.
8
COVID-19 patients with respiratory failure: what can we learn from aviation medicine?患有呼吸衰竭的新冠肺炎患者：我们能从航空医学中学到什么？
Br J Anaesth. 2020 Sep;125(3):e280-e281. doi: 10.1016/j.bja.2020.04.012. Epub 2020 Apr 18.
9
The pathophysiology of 'happy' hypoxemia in COVID-19.新型冠状病毒肺炎“快乐”低氧血症的病理生理学。
Respir Res. 2020 Jul 28;21(1):198. doi: 10.1186/s12931-020-01462-5.
10
A plea for avoiding systematic intubation in severely hypoxemic patients with COVID-19-associated respiratory failure.对避免对患有新型冠状病毒肺炎相关呼吸衰竭的严重低氧血症患者进行系统性插管的呼吁。
Crit Care. 2020 Jun 12;24(1):337. doi: 10.1186/s13054-020-03063-6.
引用本文的文献
1
Update on neurological symptoms in patients infected with severe acute respiratory syndrome coronavirus-2.新型冠状病毒2型感染患者神经系统症状的最新情况
Ibrain. 2021 Dec 20;7(4):351-361. doi: 10.1002/ibra.12008. eCollection 2021 Winter.
2
Serum Brain-Derived Neurotrophic Factor (BDNF) in COVID-19 Patients and its Association with the COVID-19 Manifestations.血清脑源性神经营养因子（BDNF）在 COVID-19 患者中的变化及其与 COVID-19 表现的关系。
J Mol Neurosci. 2022 Sep;72(9):1820-1830. doi: 10.1007/s12031-022-02039-1. Epub 2022 Jun 24.
3
Functional connectivity underlying cognitive and psychiatric symptoms in post-COVID-19 syndrome: is anosognosia a key determinant?新冠后综合征中认知和精神症状背后的功能连接性：疾病感缺失是关键决定因素吗？
Brain Commun. 2022 Mar 9;4(2):fcac057. doi: 10.1093/braincomms/fcac057. eCollection 2022.
4
Therapeutic potential of chelerythrine as a multi-purpose adjuvant for the treatment of COVID-19.白屈菜红碱作为一种多用途佐剂治疗 COVID-19 的治疗潜力。
Cell Cycle. 2021 Nov;20(22):2321-2336. doi: 10.1080/15384101.2021.1982509. Epub 2021 Sep 29.
5
Understanding the SARS-CoV-2 virus to mitigate current and future pandemic(s).了解严重急性呼吸综合征冠状病毒2（SARS-CoV-2）以减轻当前及未来的大流行。
Virusdisease. 2021 Sep;32(3):390-399. doi: 10.1007/s13337-021-00696-1. Epub 2021 Jun 5.
6
Rheumatology and psychiatry: allies in times of COVID-19.风湿病学与精神病学：COVID-19 时期的盟友。
Clin Rheumatol. 2021 Aug;40(8):3363-3367. doi: 10.1007/s10067-021-05792-7. Epub 2021 May 28.
7
Incidental chest computed tomography findings in asymptomatic Covid-19 patients. A multicentre Indian perspective.无症状新冠病毒肺炎患者胸部计算机断层扫描的偶然发现。印度多中心视角。
Indian J Radiol Imaging. 2021 Jan;31(Suppl 1):S45-S52. doi: 10.4103/ijri.IJRI_479_20. Epub 2021 Jan 23.
8
Clinical description of the broad range of neurological presentations of COVID-19: A retrospective case series.COVID-19 神经系统表现的广泛临床描述：一项回顾性病例系列研究。
Rev Neurol (Paris). 2021 Mar;177(3):275-282. doi: 10.1016/j.neurol.2021.01.004. Epub 2021 Feb 11.
9
Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms.血管紧张素转化酶 2、COVID-19 和腹主动脉瘤。
J Vasc Surg. 2021 Nov;74(5):1740-1751. doi: 10.1016/j.jvs.2021.01.051. Epub 2021 Feb 15.
10
Increased age, neutrophil-to-lymphocyte ratio (NLR) and white blood cells count are associated with higher COVID-19 mortality.年龄增长、中性粒细胞与淋巴细胞比值（NLR）和白细胞计数与 COVID-19 死亡率升高相关。
Am J Emerg Med. 2021 Feb;40:11-14. doi: 10.1016/j.ajem.2020.12.003. Epub 2020 Dec 4.
本文引用的文献
1
Clinical characteristics of 82 cases of death from COVID-19.COVID-19 死亡 82 例的临床特征。
PLoS One. 2020 Jul 9;15(7):e0235458. doi: 10.1371/journal.pone.0235458. eCollection 2020.
2
Comment on "The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients".评“SARS-CoV-2 的神经侵袭性可能在 COVID-19 患者呼吸衰竭中起作用”一文。
J Med Virol. 2020 Jul;92(7):703-704. doi: 10.1002/jmv.25960. Epub 2020 May 22.
3
Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues.SARS-CoV-2 细胞受体基因 ACE2 在多种人类组织中的表达。
Infect Dis Poverty. 2020 Apr 28;9(1):45. doi: 10.1186/s40249-020-00662-x.
4
Endothelial cell infection and endotheliitis in COVID-19.新型冠状病毒肺炎中的内皮细胞感染与内皮炎
Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.
5
Lack of dyspnea in patients with Covid-19: another neurological conundrum?新冠病毒肺炎患者无呼吸困难：另一个神经学难题？
Eur J Neurol. 2020 Sep;27(9):e40. doi: 10.1111/ene.14265. Epub 2020 May 12.
6
Neurotropism of SARS-CoV 2: Mechanisms and manifestations.新型冠状病毒2的神经嗜性：机制与表现
J Neurol Sci. 2020 May 15;412:116824. doi: 10.1016/j.jns.2020.116824. Epub 2020 Apr 8.
7
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.嗅觉和味觉障碍作为冠状病毒病（COVID-19）轻至中度形式的临床特征：一项多中心欧洲研究。
Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261. doi: 10.1007/s00405-020-05965-1. Epub 2020 Apr 6.
8
Response to Commentary on "The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients".对“SARS-CoV-2 的神经侵袭潜力可能在 COVID-19 患者呼吸衰竭中起作用”一文的评论的回应。
J Med Virol. 2020 Jul;92(7):707-709. doi: 10.1002/jmv.25824. Epub 2020 Apr 10.
9
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
10
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.SARS-CoV2 的神经侵袭性可能在 COVID-19 患者的呼吸衰竭中起作用。
J Med Virol. 2020 Jun;92(6):552-555. doi: 10.1002/jmv.25728. Epub 2020 Mar 11.
Zotero 插件